Found: 7 articles
Article | Edition |
---|---|
M.V. Leonova
Clinically significant drug interactions with warfarin: bleeding risk
|
№13 / 2022 |
P.R. Kamchatnov (1), M.A. Evzelman (2), I.V. Evgrafov (3)
EFFICACY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE USING ANTIPLATELET AGENTS AND ORAL ANTICOAGULANTS
|
№13 / 2015 |
Ya.I. Ashikhmin (1), D.Yu.Schekochikhin (2)
INDIVIDUALIZED ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION
|
№18 / 2013 |
S.G. Kanorsky
PREVENTION OF THROMBOEMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION
|
№10 / 2013 |
I.V.Zotova, D.A.Zateyshchikov
XA FACTOR INHIBITOR RIVAROXABAN IN ATRIAL FIBRILLATION
|
№9 / 2013 |
D.A. Zateyshcikov, I.V. Zotova
Dabigatran: Prospects For Clinical Application
|
№15 / 2011 |
Dankovceva E., Arhipov S., Zateyshikov D.
Intracranial Hemorrhagic Complications Against The Background Of Use Of Indirect Anticoagulants
|
№14 / 2011 |